Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | AGXT | P21549 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5831072 | 0.87 | CA1 (0.33) | TSHRIDO1KMT2AALDH1A1CA1 | |
| SCHEMBL12380718 | 0.87 | FFAR1 (0.35) | TSHRKMT2AALDH1A1CA1CA2 | |
| SCHEMBL2252915 | 0.85 | TSHR (0.41) | TSHRIDO1KMT2AAGXTALDH1A1 | |
| SCHEMBL2227585 | 0.83 | TSHR (0.40) | TSHRIDO1KMT2AAGXTALDH1A1 | |
| SCHEMBL6578072 | 0.83 | LTA4H (0.44) | TSHRALDH1A1CA1CA2HTT | |
| SCHEMBL4881254 | 0.83 | MAOB (0.34) | TSHRKMT2AALDH1A1LMNA | |
| SCHEMBL5831071 | 0.83 | TSHR (0.32) | TSHRIDO1KMT2AALDH1A1MAPK1 | |
| SCHEMBL24027472 | 0.82 | TSHR (0.36) | TSHRIDO1KMT2AAGXTALDH1A1 | |
| SCHEMBL2240873 | 0.81 | KMT2A (0.40) | TSHRIDO1KMT2AALDH1A1MAPK1 | |
| SCHEMBL2261012 | 0.81 | TSHR (0.39) | TSHRIDO1KMT2AAGXTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751521-A | Synthesis method of antitumor and antiangiogenic medicine PI-88 and precursor thereof | 陕西师范大学 | 2025-04-04 | — | — | CN | claimed |
| US-12258506-B2 | Films comprising bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2025-03-25 | — | — | US | claimed |
| EP-3707147-B1 | NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR | UNIV DEGLI STUDI DI MILANO BICOCCA (IT) | 2025-03-05 | — | — | EP | claimed |
| CN-119080856-A | Mutant tRNA for codon extension | 中外制药株式会社 | 2024-12-06 | — | — | CN | claimed |
| US-20240209257-A1 | FILMS COMPRISING BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | SHOEI CHEMICAL INC. (JP) | 2024-06-27 | — | — | US | claimed |
| US-11926776-B2 | Films comprising bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2024-03-12 | — | — | US | claimed |
| EP-4314193-A1 | STABLE AIGS FILMS | Shoei Chemical Inc. (JP) | 2024-02-07 | — | — | EP | claimed |
| CN-117396581-A | Stable AIGS film | 纳米系统公司 | 2024-01-12 | — | — | CN | claimed |
| EP-4267691-A1 | FILMS COMPRISING BRIGHT SILVER BASED QUATERNARY NANOSTRUCTURES | Nanosys, Inc. (US) | 2023-11-01 | — | — | EP | claimed |
| CN-116981754-A | Film comprising bright silver-based quaternary nanostructures | 纳米系统公司 | 2023-10-31 | — | — | CN | claimed |
| EP-2069339-A2 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | Wockhardt Research Centre (IN) | 2009-06-17 | — | — | EP | claimed |
| WO-2008058156-A9 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC (US) | 2008-12-04 | — | — | WO | claimed |
| WO-2008058156-A2 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC. (US) | 2008-05-15 | — | — | WO | claimed |
| WO-2008038092-A2 | SUBSTITUTED PIPERIDINOPHENYL OXAZOLIDINONES | WOCKHARDT RESEARCH CENTRE (IN) | 2008-04-03 | — | — | WO | claimed |
| WO-2006012425-A2 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2006-02-02 | — | — | WO | claimed |
| US-20050107600-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | CORIXA CORPORATION, A CORPORATION OF THE STATE OF DELAWARE (US) | 2005-05-19 | — | — | US | claimed |
| EP-1521762-A2 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2005-04-13 | — | — | EP | claimed |
| US-20040267007-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor | CORIXA CORPORATION | 2004-12-30 | — | — | US | claimed |
| WO-2004005308-A2 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2004-01-15 | — | — | WO | claimed |
| US-5756774-A | Synthesis of myo-inositol phosphates | ELAN PHARMACEUTICALS, INC. | 1998-05-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267007-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor | DDOST, STT3A, STT3B | TSHR 4214/4885IDO1 1271/4885KMT2A 3405/4885 |
| US-20050107600-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | DDOST, AGL, GALE | TSHR 3883/4885IDO1 1459/4885KMT2A 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.